OcuRes Consult supports partners in preclinical drug development, regulatory submissions, and investor requirements.
Why choose OcuRes Consult?
+15 Years Of Preclinical Expertise
+30 Scientific Peer-reviewed Publications
+5 Academic, CRO and Biotech Partners
More than 15 years of academic and biotech experience in preclinical ophthalmic research.
+5 Academic, CRO and Biotech Partners
+30 Scientific Peer-reviewed Publications
+5 Academic, CRO and Biotech Partners
Support to more than 5 partners, i.e. academic groups, CRO's & biotech companies.
+10 Supported Preclinical Projects
+30 Scientific Peer-reviewed Publications
+30 Scientific Peer-reviewed Publications
A track record of delivering support to more than 10 preclinical projects, in e.g., wet AMD, dry AMD, DME & glaucoma.
+30 Scientific Peer-reviewed Publications
+30 Scientific Peer-reviewed Publications
+30 Scientific Peer-reviewed Publications
Authored various scientific publications and contributed to multiple peer-reviewed publications.